![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
chevron_left Bispecific Antibodies to Treat Multiple Myeloma: An Educational Guide
Introduction
Understanding Bispecific Antibodies
Eligibility and Administration
Treatment Course
Side Effects of Bispecific Antibodies
Side Effect Management and Support
FDA Approved Bispecific Antibodies
Bispecific Antibodies in Clinical Trials
Treatment Strategies with Bispecific Antibodies
Caregiver Role in Bispecific Antibody Therapy
Financial Resources for Bispecific Antibody Therapy
Future Considerations of Bispecific Antibody Therapy
Share Your Experience
Questions to Ask Your Doctor about Bispecific Antibody Therapy
Additional Resources
chevron_left Bispecific Antibodies to Treat Multiple Myeloma: An Educational Guide
Introduction
Understanding Bispecific Antibodies
Eligibility and Administration
Treatment Course
Side Effects of Bispecific Antibodies
Side Effect Management and Support
FDA Approved Bispecific Antibodies
Bispecific Antibodies in Clinical Trials
Treatment Strategies with Bispecific Antibodies
Caregiver Role in Bispecific Antibody Therapy
Financial Resources for Bispecific Antibody Therapy
Future Considerations of Bispecific Antibody Therapy
Share Your Experience
Questions to Ask Your Doctor about Bispecific Antibody Therapy
Additional Resources
Infection Risk (2/3)
Last updated on: 8/1/2024
What are potential infections from bispecific antibody treatment?
Because bispecific antibody therapy compromises the immune system, signs of common infections such as pneumonia, COVID-19 or upper respiratory tract infections must be taken seriously, monitored closely, and reported to your doctor.
Symptoms of these common infections could be:
Other infections from bispecific antibodies could include:
